Francis A. Farraye, MD, MSc
Scientific Advisor, Gastroenterology
Dr. Francis A. Farraye is a physician in the Inflammatory Bowel Disease Center and Division of Gastroenterology and Hepatology at Mayo Clinic hospital in Jacksonville, Florida. His area of expertise is in the management of patients with Ulcerative Colitis and Crohn’s Disease. A frequent speaker and invited lecturer on topics on the diagnosis and management of Inflammatory Bowel Disease, Dr. Farraye has authored or co-authored over 450 original scientific manuscripts, chapters, reviews, and abstracts. Before joining Mayo Clinic, Dr. Farraye was a Professor of Medicine at the Boston University School of Medicine and served as Clinical Director in the Section of Gastroenterology and Director of the Inflammatory Bowel Disease Center at Boston Medical Center. Dr. Farraye received a MD from Albert Einstein College of Medicine in New York and a MSc (Epidemiology) from Harvard University.
Paul Ginsburg, PhD
Scientific Advisor, Intellectual Property
Dr. Paul Ginsburg is considered one of the foremost patent experts in the pharmaceutical and biotechnology fields. Dr. Ginsburg lectures widely on patent prosecution and licensing. Earlier in his career, he served as Head of the New York Patent Department at Pfizer Inc. Prior to his 20-year career at Pfizer, he was a senior attorney at Schering-Plough. Dr. Ginsburg was subsequently recruited by Merck and then by Fish & Neave. He is perhaps most well-known for authoring the patent covering Schering-Plough's blockbuster drug, Claritin. Since 2011, Dr. Ginsburg has advised Innovation, including authoring the patent for Kevetrin. He was elected to Phi Beta Kappa at the City College of New York. Dr. Ginsburg received a PhD (Chemistry) from the City University of New York and a JD from Columbia University.
Stephen Sonis, DMD, DMSC
Scientific Advisor, Oral Mucositis
Dr. Sonis is one of the world’s foremost experts in the research and clinical treatment of cancer-related oral mucosal toxicities. He currently holds appointments at the Harvard School of Dental Medicine as Professor of Oral Medicine (part-time), and is a Senior Surgeon at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital. Dr. Sonis also is a Founder and Chief Scientific Officer of Biomodels, LLC, a preclinical contract research organization. Widely respected by his professional peers, he is the author of over 250 original publications, reviews and chapters, 11 books, and 5 patents, serves on a number of editorial boards, and is a founding member of the International Society of Oral Oncology and the International Academy of Oral Oncology. Dr. Sonis is a graduate of Tufts University and Harvard University and completed his post-doctoral education at Oxford University.